FDA food adverse event report
Consumer gender: Male
Consumer age: 9 day(s)
Product(s):
role: SUSPECT
name_brand: EVIVO BIFIDOBACTERIUM INFANTIS (EVIVO) ORAL SUSPENSION
industry_name: Dietary Conventional Foods/Meal Replacements
Reactions:
Abdominal distension
Bacteraemia
Bradycardia neonatal
Disturbance of thermoregulation of newborn
Premature baby
Respiratory failure
Sepsis
Outcomes:
Hospitalization
Other Serious or Important Medical Event